MedPath

CONTROLLED STUDY OF FERRIC POLYMATOSATE VS FERRITINE IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO 2 YEARS OLD.

Not Applicable
Conditions
-D508 Other iron deficiency anaemias
Other iron deficiency anaemias
D508
Registration Number
PER-068-02
Lead Sponsor
VIFOR INTERNACIONAL,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. You must have the consent of the informed consent.
2. Have an age between 6 months and 2 years
3. Diagnosis of hlpochromic and microcytic anemia.
4. Hemoglobin S 8 and <10 g / dl.
5. Be able to attend the consultation according to the study schedule.
6. Be included in the percenfiles 10 - 90. Pondo-statural for age and sex according to the tables of the NCHS.

Exclusion Criteria

1. History of intolerance to iron salts.
2. History of chronic anemia resistant to treatment.
3. Acute pathologies (e.g., acute infections) or chronic diseases (e.g. intestinal malabsorption syndrome) that can modify the blood values.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>
Secondary Outcome Measures
NameTimeMethod
<br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>
© Copyright 2025. All Rights Reserved by MedPath